Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given ...

Shares of Milestone Pharmaceuticals climbed after the company said its first commercial product, Cardamyst nasal spray, was approved by the Food and Drug Administration to treat paroxysmal ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...

A 65-year-old man receives a right coronary artery stent after a NSTEMI. What does his postsurgery ECG look like?

The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...

Smartwatches and wearable heart monitors can help detect issues such as irregular heart rhythms. But they also have limits ...

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

"Holiday heart syndrome" is an umbrella term for several cardiac complications that occur during the winter holiday season.

Huxley Medical, Inc. announced the SANSA® home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...

Transient loss of vision is associated with an increased risk for cardiovascular events within 14 days of diagnosis, and ...

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at University of Michigan ...